Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies [Phase 3]
Phase 3 randomized study evaluating obicetrapib added to maximum tolerated lipid-modifying therapies has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of adding ezetimibe early to atorvastatin in very high-risk patients with atherosclero…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure [NA]
This study evaluates using polygenic risk scores to stratify patients for blood pressure management in hypertension and atherosclerotic card…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Guideline Oriented Approach To Lipid Lowering In Asia-Pacific [NA]
A clinical trial in the Asia-Pacific region evaluating guideline-oriented lipid-lowering strategies for patients with cardiovascular disease…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial investigating late subclinical cardiovascular disease in testicular cancer survivors has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: ACHIEVE Pilot Statins for Vascular Protection
The ACHIEVE pilot trial investigates statins for vascular protection in patients with atherosclerotic cardiovascular disease. The study is c…
-
FDA approval · 2025-08-06FDA Approved: ICOSAPENT ETHYL — Original Application (Vitruvias Therapeutics, Inc.)
FDA approved the original application for ICOSAPENT ETHYL by Vitruvias Therapeutics, Inc., enabling a generic version of the triglyceride-lo…
-
FDA approval · 2025-08-05FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for pravastatin sodium, authorizing continued marketing of the product as a stati…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Novartis is conducting a clinical trial in Russia to assess lipoprotein(a) levels in patients with atherosclerotic cardiovascular disease.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients? [NA]
A Duke University–sponsored study called Test 2 Treat aims to determine whether education for physicians and patients improves testing and t…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events [Phase 2]
Phase 2 trial evaluating SLN360 in participants with elevated lipoprotein(a) at high risk of atherosclerotic cardiovascular disease. The tri…
-
FDA approval · 2025-06-26FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for pravastatin sodium from Dr. Reddy's Laboratories Limited. This pertains to a generic pravastatin…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Telehealth Group Counseling and Preventive Care for Women [NA]
A completed clinical trial evaluating telehealth group counseling and preventive care for women with cardiovascular conditions, including AS…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Patterns of Inclisiran Use in the Real World: An Analysis of US Databases
This clinical trial update analyzes real-world use patterns of inclisiran in US databases for patients with atherosclerotic cardiovascular d…
-
FDA approval · 2025-06-13FDA Approved: PITAVASTATIN — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for pitavastatin calcium by Teva Pharmaceuticals, updating/expanding the existing approval for this …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease [Phase 2]
Phase 2 trial evaluating Novo Nordisk’s NNC0385-0434 tablets for lowering blood cholesterol in people with atherosclerotic cardiovascular di…
-
CLINICAL_TRIALS other · 2025-06-03Clinical Trial Update: Managed Access Programs for TQJ230, Pelacarsen
Clinical trial update notes available managed access programs for Pelacarsen (TQJ230) targeting atherosclerotic cardiovascular disease, spon…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women [Phase 2]
A completed Phase 2 multicenter trial investigating meditation and health education for cardiometabolic disease in Black women.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease [Phase 4]
A Phase 4 clinical trial is evaluating tirzepatide in people with overweight/obesity and coronary artery disease and is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
A completed real-world study evaluating the effect of semaglutide on cardiovascular outcomes in adults with overweight or obesity.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease [Phase 1]
Phase 1 trial update reporting completion of the study of VERVE-101 in patients with heterozygous familial hypercholesterolemia and cardiova…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients [NA]
A pragmatic clinical trial evaluating a pharmacist-led team approach to managing LDL-cholesterol in patients with atherosclerotic cardiovasc…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease [Phase 4]
Phase 4 clinical trial update evaluating metformin hydrochloride sustained-release tablets in patients with type 2 diabetes mellitus and ath…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis [Phase 1, Phase 2]
It reports the completion of a Phase 1/Phase 2 trial of YN001 in healthy subjects and patients with atherosclerotic cardiovascular disease (…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: The Prevent Coronary Artery Disease Trial [Phase 3]
This clinical trial update describes a Phase 3 study assessing prevention of atherosclerotic cardiovascular disease. The trial is currently …